As of 2025-09-17, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 21.3x | 19.2x |
| Forward P/E multiples | 21.2x - 22.4x | 22.4x |
| Fair Price | (89.62) - (89.78) | (87.96) |
| Upside | -263688.1% - -264152.4% | -258812.9% |
| Date | EV/EBITDA |
| 2025-07-25 | -1.49 |
| 2025-07-23 | -1.49 |
| 2025-07-17 | -1.49 |
| 2025-07-16 | -1.49 |
| 2025-07-15 | -1.49 |
| 2025-07-14 | -1.49 |
| 2025-07-11 | -1.49 |
| 2025-07-10 | -1.49 |
| 2025-07-09 | -1.49 |
| 2025-07-08 | -1.49 |
| 2025-07-07 | -1.49 |
| 2025-07-03 | -1.49 |
| 2025-07-02 | -1.49 |
| 2025-07-01 | -1.49 |
| 2025-06-30 | -1.49 |
| 2025-06-27 | -1.49 |
| 2025-06-26 | -1.49 |
| 2025-06-25 | -1.49 |
| 2025-06-24 | -1.49 |
| 2025-06-23 | -1.49 |
| 2025-06-20 | -1.49 |